{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:14:50Z","timestamp":1783646090084,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004699","name":"Chung Shan Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019019","name":"Department of Medical Research, Union of Myanmar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaad.2026.03.044","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:40:39Z","timestamp":1773942039000},"page":"269-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced prostate cancer risk in patients with androgenetic alopecia using 5-alpha reductase inhibitors: A TriNetX real-world cohort study"],"prefix":"10.1016","volume":"95","author":[{"given":"Yu-Jen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-9486","authenticated-orcid":false,"given":"Wei-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.03.044_bib1","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2023.05.004","article-title":"Medical and procedural treatment of androgenetic alopecia - where are we?","volume":"89","author":"Ly","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.03.044_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.03.044_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1215932","article-title":"Long-term survival of participants in the prostate cancer prevention trial","volume":"369","author":"Thompson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.03.044_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.urology.2020.05.105","article-title":"Prostate cancer risk and prognostic influence among users of 5-alpha-reductase inhibitors and alpha-blockers: a systematic review and meta-analysis","volume":"145","author":"Wu","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.jaad.2026.03.044_bib5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.juro.2009.01.071","article-title":"Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology\/American Urological Association 2008 Clinical Practice Guideline","volume":"181","author":"Kramer","year":"2009","journal-title":"J Urol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226004202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226004202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:58:40Z","timestamp":1783645120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226004202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0190962226004202"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.03.044","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced prostate cancer risk in patients with androgenetic alopecia using 5-alpha reductase inhibitors: A TriNetX real-world cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.03.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}